PharmaHandbook™ provides pharmaceutical industry decision-makers with a single source of accurate, up-to-date statistics, information and analysis on prescription drug business and regulatory environments throughout the world.
Topics covered include:
- Private and public healthcare systems
- Regulatory bodies
- Approval procedures
- Pricing regulations
- Parallel trade & intellectual property issues
- Population & prescriber characteristics
- Sales channels
- Sales & consumption
- Branded vs. generic use
- Growth rates
- Payment patterns
- Marketing practices
- Industry associations
- Contact information for key players in each market
Who should have it:
Anyone who is affiliated with the pharmaceutical, biotech or healthcare industries, including industry executives, policy makers, consultants, investors, analysts, CROs, marketing partners or advocacy groups will benefit enormously from the information.
Please note: This version covers Egypt only.
PharmaHandbook is also available for purchase across the following regions.
EU: EU Overview, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, UK
ASIA PACIFIC: Australia, China, India, Indonesia, Japan, Korea, New Zealand, Taiwan, Thailand, Vietnam
MIDDLE EAST & AFRICA: Egypt, Israel, Saudi Arabia, South Africa, Turkey
EUROPE (NON-EU): Russia, Switzerland
LATIN AMERICA: Argentina, Brazil, Chile, Mexico, Venezuela
NORTH AMERICA: Canada, United States
For further details, please search our website.